Table 3.
IC50 of Tamoxifen, Doxorubicin, 5-Fluorouracil and Cisplatin on HepG2, MCF7, A549 and HT29 after 24, 48 and 72 h of incubation.
| Cell Lines | Duration (hours) | IC50 |
|---|---|---|
| HepG2 | IC50 (Tamoxifen) | |
| 24 | 4.94 ± 1.16 | |
| 48 | 3.80 ± 0.66 | |
| 72 | 2.1 ± 0.9 | |
| MCF7 | IC50 (Doxorubicin) | |
| 24 | 2.46 ± 0.34 | |
| 48 | 1.93 ± 1.13 | |
| 72 | 0.9 ± 0.78 | |
| HT29 | IC50 (5-Fluorouracil) | |
| 24 | 3.26 ± 0.27 | |
| 48 | 2.57 ± 1.17 | |
| 72 | 1.27 ± 0.8 | |
| A549 | IC50 (Cisplatin) | |
| 24 | 2.47 ± 0.67 | |
| 48 | 1.95 ± 0.81 | |
| 72 | 1.04 ± 0.4 |